Track topics on Twitter Track topics that are important to you
HERSHEY, Pa. and ROCKVILLE, Md., June 3, 2015 (GLOBE NEWSWIRE) -- Immunomic Therapeutics, Inc. ("ITI"), a privately-held biotechnology company developing vaccines based on its proprietary LAMP technology, today announces that the company's CEO, William Hearl, Ph.D., will be one of the featured speakers at this year's Biotechnology Industry Organization (BIO) International Convention on June 15-18 at the Pennsylvania Convention Center in Philadelphia.
Dr. Hearl will be discussing the company's LAMP-vax platform technology, as well as current plans. He will be speaking on Wednesday, June 17th at 9:45 AM (EDT) as part of the Vaccines track in Theater 3, dubbed "Doctor Nucleus." In addition, the company will have an exhibition booth at the Pennsylvania Pavilion, #4227. For planning purposes, please visit: http://www.mapyourshow.com/shows/index.cfm?Show_ID=bio15&exhid=00112242&booth=4227A&hall=A
"We are gratified for the opportunity to address our industry peers at BIO to discuss Immunomic's unique approach to solving the allergy problem," said Dr. Hearl. "The BIO convention has long been an opportunity to share ideas, create new collaborations and take note of what's happening in our industry."
About Immunomic Therapeutics, Inc.
Immunomic Therapeutics, Inc. (ITI) is a Hershey, PA-based, privately held, clinical stage biotechnology company developing vaccines based on the LAMP technology platform, which was exclusively licensed from Johns Hopkins University. The LAMP-vax vaccine platform aims to increase the immune response to nucleic acid vaccines and simplify vaccine design and delivery for safer, more cost-effective therapies. ITI's LAMP constructs have been validated in human clinical trials for cancer and have been studied in areas including allergy and infectious disease, while internally ITI is focused on developing allergy therapies. Currently, the company is pursuing three main allergy programs:
For more information about ITI and LAMP Technology, please visit www.immunomix.com.
CONTACT: Jules Abraham JQA Partners, Inc. 917-885-7378 email@example.comNEXT ARTICLE
Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...
The term allergy is used to describe a response, within the body, to a substance, which is not necessarily harmful in itself, but results in an immune response and a reaction that causes symptoms and disease in a predisposed person, which in turn can cau...